Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 28, 2020; 26(44): 7076-7084
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.7076
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.7076
Table 1 Laboratory tests of patients
| No symptoms | Start symptoms | Start treatment | After treatment | |
| Laboratory parameters | February 22 | March 10 | March 16 | March 24 |
| AST, UI/L | 24 | 22 | 32 | 26 |
| ALT, UI/L | 19 | 28 | 16 | 24 |
| Total bilirubin (µmol/L) | 6.5 | 3.5 | 8 | 8 |
| Albumin (g/L) | 33 | 35 | 33 | 31 |
| Creatinine (µmol/L) | 118.6 | 119 | 135 | 134.5 |
| Hemoglobin (g/L) | 12.1 | 12.5 | 12.5 | 11.7 |
| Platelet | 159000 | 122000 | 136000 | 296000 |
| Lymphocytes | 1020 | 1050 | 390 | 996 |
| PT (%) | 100 | 86 | 27 | 88 |
| INR | 1 | 1.05 | 1.5 | 1.1 |
| Tacrolimus (ng/mL) | 3.5 | 3.5 | 3.2 | 3.8 |
| CRP (mg/L) | 3.05 | 12.4 | 112.28 | 6.6 |
Table 2 Clinical and biological characteristics of patients with coronavirus disease 2019 pneumonia after liver transplanta
| Ref. | Study type | Patients (n) | Age (yr) | Time from transplantation | Clinical manifestations | Immunosuppression treatment | Immunosuppression, modification | Metabolic comorbidities | Death |
| Fernández-Ruiz et al[8] | Case series | 6 | 63 | 7.9 yr | Fever, shortness of breath, cough | EVE | Yes | Hypertension, diabetes | No |
| 72 | 5.5 yr | Fever, shortness of breath, cough | MMF, EVE | Yes | Hypertension, diabetes, obesity | Yes | |||
| 79 | 15.3 yr | Shortness of breath, cough, malaise, diarrhea | Prednisone AZA, EVE | Yes | Diabetes, chronic renal failure | Yes | |||
| 73 | 16.4 yr | Fever, shortness of breath, cough, malaise | MMF | Yes | Diabetes | Yes | |||
| 76 | 26.5 yr | Fever, thoracic, pain | Tacrolimus | No | Hypertension | No | |||
| 46 | 6.4 yr | Diarrhea | Tacrolimus | No | No | ||||
| Bhoori et al[7] | Correspondence | 6 | > 65 | > 10 yr | Yes | Yes | |||
| > 65 | > 10 yr | Yes | Diabetes, overweight, hyperlipidemia | Yes | |||||
| > 65 | > 10 yr | Yes | Diabetes, overweight, hyperlipidemia | Yes | |||||
| < 2 yr | Calcineurin inhibitors | Yes | Diabetes, overweight, hyperlipidemia | No | |||||
| < 2 yr | Calcineurin inhibitors | Yes | No | ||||||
| < 2 yr | Calcineurin inhibitors | Yes | No | ||||||
| Huang et al[9] | Case report | 1 | 59 | 3 yr | Fever, cough, chills, fatigue, icterus and diarrhea | MMF et tacrolimus | Yes | ||
| Qin et al[6] | Case report | 1 | 37 | 53 d | Persistent fever | Tacrolimus and glucocorticoids | No |
- Citation: Sessa A, Mazzola A, Lim C, Atif M, Pappatella J, Pourcher V, Scatton O, Conti F. COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report. World J Gastroenterol 2020; 26(44): 7076-7084
- URL: https://www.wjgnet.com/1007-9327/full/v26/i44/7076.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i44.7076
